Pharma Journalist -

Scribe Therapeutics, Inc. has achieved a second success milestone in its ongoing collaboration with Eli Lilly and Company, marking further progress in the development of in vivo…
Read More...

Teijin Pharma Limited has signed a joint research agreement with Aska Pharmaceutical Co., Ltd. to develop new small-molecule drug candidates for gynecological diseases, marking a…
Read More...

The Investigative & Preclinical Toxicology Summit (May 12-14 | Boston, MA) is set to redefine toxicology meetings for biotech and pharmaceutical professionals. Unlike traditional…
Read More...

Immunic, Inc. announced it has priced a private placement expected to generate up to $400 million in gross proceeds, funding the company’s shift from a research-focused biotech to a…
Read More...

Disc Medicine said the U.S. Food and Drug Administration has issued a Complete Response Letter (CRL) for its New Drug Application seeking approval of bitopertin to treat erythropoietic…
Read More...

PTC Therapeutics has withdrawn its resubmitted New Drug Application for Translarna (ataluren) to treat nonsense mutation Duchenne muscular dystrophy after receiving review feedback from…
Read More...

China-based biotech developer Shanghai Ark Biopharmaceutical Co., Ltd. has received clearance from the U.S. Food and Drug Administration to begin a U.S. clinical study of its…
Read More...

French pharmaceutical group Sanofi announced a leadership transition after its board decided not to renew the mandate of Chief Executive Officer Paul Hudson. His final day leading the…
Read More...

Biotechnology company Amgen has received authorization from the European Commission for UPLIZNA as an add-on therapy for adults with generalized myasthenia gravis (gMG) who test…
Read More...

Pharmaceutical giant Merck & Co., Inc. — known internationally as MSD — has received U.S. regulatory approval for expanded use of its immunotherapy KEYTRUDA and the newer…
Read More...